(1 - 18 from 21
)
Grifols announces FDA approval of Xembify®, www.grifols.com › view-news › news › grifols-announces-fda-approv...
www.grifols.com
According to Joel Abelson, President of Commercial Bioscience Division, “This approval reinforces Grifols' longstanding commitment to ...
Grifols launches XEMBIFY® (immune globulin subcutaneous ...apnews.com › ...
apnews.com
... an important new medicine for PI patients in the United States,” said Joel Abelson, President, Bioscience Commercial Division. “Adding to our ...
sorted by relevance / date